SKI Market

A+| A| A-|

Indian Indices

Sensex

75,315.04 77.05
( 0.10%)

Global Indices

Nasdaq

49,543.85 -540.61
(-1.08%)

Dow Jones

7,428.26 -93.98
(-1.25%)

Hang Seng

60,874.73 -534.56
(-0.87%)

Nikkei 225

10,297.25 101.88
(1.00%)

Forex

USD-INR

95.71 0.07
(0.07%)

EUR-INR

111.93 -0.13
(-0.12%)

GBP-INR

129.01 -0.31
(-0.24%)

JPY-INR

0.61 0.00
(-0.09%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Advanced Enzyme Technologies Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

540025

INE837H01020

63.3737836

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ADVENZYMES

30.18

4075.37

EPS(TTM)

Face Value()

Div & Yield %

12.06

0.37

Back

magnum ventures ltd

Healthcare Global Enterprises standalone net profit declines 39.94% in the September 2025 quarter

Nov 13,2025

Net profit of Healthcare Global Enterprises declined 39.94% to Rs 10.78 crore in the quarter ended September 2025 as against Rs 17.95 crore during the previous quarter ended September 2024. Sales rose 4.86% to Rs 344.41 crore in the quarter ended September 2025 as against Rs 328.45 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	344.41	328.45	5
OPM %	18.09	18.75	-
PBDT	44.76	50.79	-12
PBT	14.60	22.91	-36
NP	10.78	17.95	-40

75,315.04 77.05 ( 0.10%)

49,543.85 -540.61 (-1.08%)

7,428.26 -93.98 (-1.25%)

60,874.73 -534.56 (-0.87%)

10,297.25 101.88 (1.00%)

95.71 0.07 (0.07%)

111.93 -0.13 (-0.12%)

129.01 -0.31 (-0.24%)

0.61 0.00 (-0.09%)